LAB. FARMACEUTICOS ROVI, SA. secures contract for 2026/0519 - Direct Contracting For The Acquisition Of Risperidone [100 Mg/0490 Ml; Inj Lp Susp Powder; Syringe] And Risperidone [75 Mg/0383 Ml; Inj Lp Susp Powder; Syringe]

Portugal, Oct. 6 -- Portugal based LAB. FARMACEUTICOS ROVI, SA. has secured contract from Unidade Local De Saude Do Alto Minho, Epe (Ulsam) for 2026/0519 - Direct Contracting For The Acquisition Of Risperidone [100 Mg/0490 Ml; Inj Lp Susp Powder; Syringe] And Risperidone [75 Mg/0383 Ml; Inj Lp Susp Powder; Syringe]. The value of the contract is worth 26610.2 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....